Antitumor activity of a homo-aza-steroidal ester of (p-(bis(2-chloroethyl)amino)phenyl)acetic acid (NSC-71964).
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001372:Aza Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D001378:Azasteroids; D001855:Bone Marrow Diseases / Q000139:chemically induced; D003520:Cyclophosphamide / Q000627:therapeutic use; D004952:Esters / Q000009:adverse effects / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006394:Hemangiosarcoma / Q000188:drug therapy*; D007928:Lethal Dose 50; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use*; D051381:Rats; D013158:Splenic Diseases / Q000139:chemically induced; D013256:Steroids / Q000009:adverse effects; D013997:Time Factors
D000970:Antineoplastic Agents; D001372:Aza Compounds; D001378:Azasteroids; D004952:Esters; D009588:Nitrogen Mustard Compounds; D010648:Phenylacetates; D013256:Steroids; C017888:NSC 290205; D003520:Cyclophosphamide